Literature DB >> 1332662

Generation of plasma kinin by three types of protease isolated from Porphyromonas gingivalis 381.

D Hinode1, A Nagata, S Ichimiya, H Hayashi, M Morioka, R Nakamura.   

Abstract

Three types of protease (A, B and C) isolated from the culture supernatant of Porphyromonas gingivalis 381 had peculiar activities on kinin generation from high molecular-weight kininogen in vitro. Protease C released bradykinin from the kininogen in a reaction mixture containing 2 mM dithiothreitol, but A and B did not. However, the activity of degrading bradykinin was much stronger in protease A and B than in C. These findings suggest that only protease C shows plasma kallikrein activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1332662     DOI: 10.1016/0003-9969(92)90120-w

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  5 in total

1.  Mechanisms mediating Porphyromonas gingivalis gingipain RgpA-induced oral mucosa inflammation in vivo.

Authors:  I Rubinstein; J Potempa; J Travis; X P Gao
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Modification of cystatin C activity by bacterial proteinases and neutrophil elastase in periodontitis.

Authors:  M Abrahamson; M Wikström; J Potempa; S Renvert; A Hall
Journal:  Mol Pathol       Date:  1997-12

3.  Pathogenesis of periodontitis: a major arginine-specific cysteine proteinase from Porphyromonas gingivalis induces vascular permeability enhancement through activation of the kallikrein/kinin pathway.

Authors:  T Imamura; R N Pike; J Potempa; J Travis
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

4.  Dependence of vascular permeability enhancement on cysteine proteinases in vesicles of Porphyromonas gingivalis.

Authors:  T Imamura; J Potempa; R N Pike; J Travis
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

5.  Anti-inflammatory and analgesic activity of the bradykinin antagonist, icatibant (Hoe 140), against an extract from Porphyromonas gingivalis.

Authors:  T Griesbacher; R L Sutliff; F Lembeck
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.